EAM Investors’s Lifecore Biomedical LFCR Stock Holding History

EAM Investors’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-91,364	Closed	-$1.21M	–	343
2013 Q2	$1.21M	Buy	+91,364	New	+$1.26M	0.26%	142

Other funds holding LFCR

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM Investors's LFCR Position: Q3 2013 in Review

EAM Investors sold out of Lifecore Biomedical (LFCR) in Q3 2013, closing a stake of 91,364 shares — an estimated $1.21M sold.

EAM Investors first reported a position in LFCR in Q2 2013 and held it in 1 quarter. The position peaked at $1.21M in Q2 2013. 125 funds tracked by Wall St. Rank hold LFCR as of Q3 2013.

EAM Investors reported no remaining Lifecore Biomedical position as of Q3 2013 after selling out during the quarter.
EAM Investors sold 91,364 Lifecore Biomedical shares in Q3 2013, an estimated $1.21M.
EAM Investors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 1 quarter.
EAM Investors's Lifecore Biomedical position peaked at $1.21M in Q2 2013.
125 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2013.

Based on EAM Investors's 13F filing for Q3 2013, filed 13 Nov 2013.